Lytix Biopharma

Developer of oncolytic peptide immunotherapy for solid tumors

placeOslo, Oslo, Norway calendar_todayFounded 2003 groups7 employees language lytixbiopharma.com

Registered entities

Social engagement

Social engagement: 5.2K social following, 9 posts in the last 12 months — above the industry median.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital120%
Private equity120%
Other / undisclosed360%

Recent activity

11 Jun 2026
Event
BIO International Convention
28 May 2026
Event
ASCO2026
22 May 2026
Event
ASCO Annual Meeting 2026
Coming soon